Author:
Abate Miseker,Drebin Harrison,Shimada Shoji,Fei Teng,McKinley Sophia,Poruk Katherine,Ferguson Ben,Neuwirth Madalyn,Tang Laura H.,Vardhana Santosha,Strong Vivian E.
Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
2. Deng J-Y, Liang H. Clinical significance of lymph node metastasis in gastric cancer. World J Gastroenterol. 2014;20:3967–75.
3. Ajani JA, D’Amico TA, Bentrem DJ, et al. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022;20:167–92.
4. Mogal H, Fields R, Maithel SK, Votanopoulos K. In patients with localized and resectable gastric cancer, what is the optimal extent of lymph node dissection, D1 versus D2 versus D3? Ann Surg Oncol. 2019;26:2912–32.
5. Degiuli M, Sasako M, Ponti A, et al. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg. 2014;101:23–31.